相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
Jenny Bostrom et al.
SCIENCE (2009)
Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro
M. K. Robinson et al.
BRITISH JOURNAL OF CANCER (2008)
Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin
Chengbin Wu et al.
NATURE BIOTECHNOLOGY (2007)
Selective targeting and potent control of tumor growth using an EphA2/CD3-bispecific single-chain antibody construct
Scott A. Hammond et al.
CANCER RESEARCH (2007)
Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis
Flavia De Bernardis et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Structure-guided SCHEMA recombination of distantly related β-lactamases
Michelle M. Meyer et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2006)
Single variable domain-IgG fusion - A novel recombinant approach to Fc domain-containing bispecific antibodies
JQ Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Physically realistic homology models built with ROSETTA can be more accurate than their templates
KMS Misura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma
DA Vallera et al.
CLINICAL CANCER RESEARCH (2005)
T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro
JM Gall et al.
EXPERIMENTAL HEMATOLOGY (2005)
A revival of bispecific antibodies
P Kufer et al.
TRENDS IN BIOTECHNOLOGY (2004)
Insights into IgA-mediated immune responses from the crystal structures of human FcαRI and its complex with IgA1-Fc
AB Herr et al.
NATURE (2003)
Bispecific antibody conjugates in therapeutics
Y Cao et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Synergistic antitumor effect of bispecific CD19 x CD3 and CD19 x CD16 diabodies in a preclinical model of non-Hodgkin's lymphoma
SM Kipriyanov et al.
JOURNAL OF IMMUNOLOGY (2002)
Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc
EE Idusogie et al.
JOURNAL OF IMMUNOLOGY (2000)